Atom Investors LP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
Atom Investors LP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$17,039
-19.8%
13,1070.0%0.00%
-50.0%
Q2 2023$21,233
-23.9%
13,1070.0%0.01%
-46.7%
Q1 2023$27,918
-59.3%
13,107
-29.2%
0.02%
-55.9%
Q4 2022$68,531
+226.3%
18,522
-35.7%
0.03%
+385.7%
Q3 2022$21,000
-12.5%
28,821
-5.3%
0.01%
-30.0%
Q2 2022$24,000
-14.3%
30,4220.0%0.01%
-23.1%
Q1 2022$28,00030,4220.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2023
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$18,010,7836.83%
M28 Capital Management LP 1,910,600$7,069,2206.74%
Opaleye Management Inc. 1,460,000$5,402,0001.88%
Ikarian Capital, LLC 422,625$1,563,7130.38%
Monaco Asset Management SAM 165,000$610,5000.18%
AWM Investment Company, Inc. 166,667$616,6680.09%
FRANKLIN STREET ADVISORS INC /NC 150,000$5550.05%
Atom Investors LP 18,522$68,5310.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$13,414,2280.03%
GSA CAPITAL PARTNERS LLP 21,514$800.01%
View complete list of PROQR THRAPEUTICS N V shareholders